RSV MD Support Materials

What is currently going on with RSV, Respiratory Syncytial Virus infections in the United States? Up to date RSV Case Surveillance can be viewed at RSV-Net .  As these RSV cases begin their seasonal up-tick and RSV unfortunately gets underway physicians caring for the very youngest patients, the more vulnerable and the older may like to add information about RSV and current RSV prevention strategies to their websites other digital marketing campaigns.  RSV vaccines and nirsevimab-alip innovations are in their second season so patients and parents may not realize these advancements are here.  Manufacturers of RSV vaccines for adults, GSK with Arexvy, Pfizer with Abrysvo, and Moderna with mResvia all have healthcare provider support materials.

For the infants protection from RSV infection afforded via the monoclonal antibody, Beyfortus, medical Practices may take advantage of “ Ready to Go” Social Media Materials.

Sanofi offers a suite of complimentary resources to assist physicians in their infant RSV prevention efforts. These resources include a concise educational video designed to familiarize parents with Beyfortus® (nirsevimab-alip). Furthermore, physicians can now proudly communicate to their patients that this groundbreaking medical advancement is available at their practice.

These videos may be added to medical practice websites, social media pages and other communications regarding the availability of Beyfortus, nirsevimab-alip in the office.  Most immunization and disease prevention resources Sanofi’s team has created for physicians are available in both English and Spanish as well as these brief but informative RSV prevention videos.  Click here for the Spanish RSV Parent Education Video and click here for the English RSV Parent Education Video.

Practices participating in the Physician Buying Group, PracticeWell, gain access to preferential pricing on RSV vaccines: Abrysvo, Arexvy, and mResvia, as well as Beyfortus. Join the PracticeWell community today and optimize your vaccine acquisition strategy.